ALICIA DAVIDSON: Open Payments
NPI 1235625187 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 37 payments from 22 companies in 2025. Trend: 2023 $1,158 · 2024 $472 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 4 | $182 |
| Lilly USA, LLC | 2 | $136 |
| ABBVIE INC. | 2 | $134 |
| Dexcom, Inc. | 1 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $110 |
| Exeltis, USA Inc. | 4 | $60 |
| Sage Therapeutics, LLC | 2 | $57 |
| MILLICENT US INC | 3 | $50 |
| Astellas Pharma US Inc | 2 | $44 |
Products named: ACCRUFER, DEXCOM G7 GSS (161), Kerendia, QULIPTA, ZEPBOUND, AUSTEDO XR, SLYND, ZURZUVAE.
Industry payments across KY — which companies pay providers there.
